![](https://monteverdelaw.com/wp-content/uploads/Screenshot-2024-07-30-130243.png)
Augmedix, Inc. (Nasdaq: AUGX), relating to its proposed merger with Commure, Inc. Under the terms of the agreement, Augmedix stock will be converted into the right to receive $2.35 in cash per share.
Augmedix, Inc. (Nasdaq: AUGX), relating to its proposed merger with Commure, Inc. Under the terms of the agreement, Augmedix stock will be converted into the right to receive $2.35 in cash per share.